Matthias Schieker

机构：Novartis (Switzerland), ETH Zurich, Novartis (China) · ORCID：0000-0002-1230-3653

发表论文 203 篇 · 总被引 8265 次 · h-index 50

代表论文

• Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement (2020 · Annals of Internal Medicine · 被引 170)
• Bone regeneration of minipig mandibular defect by adipose derived mesenchymal stem cells seeded tri-calcium phosphate- poly(D,L-lactide-co-glycolide) scaffolds (2020 · Scientific Reports · 被引 94)
• Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial (2022 · Nature Medicine · 被引 65)
• Pain-phenotyping in osteoarthritis: Current concepts, evidence, and considerations towards a comprehensive framework for assessment and treatment (2024 · Osteoarthritis and Cartilage Open · 被引 45)
• Relationship between tendon structure, stiffness, gait patterns and patient reported outcomes during the early stages of recovery after an Achilles tendon rupture (2020 · Scientific Reports · 被引 33)
• Unsupervised machine-learning algorithms for the identification of clinical phenotypes in the osteoarthritis initiative database (2022 · Seminars in Arthritis and Rheumatism · 被引 28)